PHASE II - Medical Marketing

> Market access professionals

In your role as Market Access Manager defining what is needed for successful market access of your company's product is an important first step.

You may have already started to execute a range of integrated programs and approaches tailored to your company's product/therapy area e.g. studies on disease awareness or the burden of an illness; value demonstration; health policy influencing and implementation; organizing advisory panels with key stakeholders to engage key targets; and gathering the right intelligence to begin influencing these stakeholders.

PHASE II International has extensive experience in market access and value demonstration, encompassing economic strategies, development of value dossiers as well as a considerable track record of conducting retrospective/prospective pharmacoeconomic studies. All of these are aimed at not only getting your product ready for the market; but getting the market ready for your product.

Browse this section to review our market access capabilities.

Target product profile (TPP) optimization

Regulatory documentation

Market research/analytics

Business intelligence

Market modeling/forecasting

Business intelligence

Competitor intelligence

Key opinion leaders

Product positioning

Communications strategy

Pre-marketing project plan

Business plan development

Pharmacoeconomic

Pricing and reimbursement

Market access

Adoption

Lifecycle

AstraZeneca Mental Health Policy Implementation Resource

AstraZeneca Burden of GERD

“PHASE II International is helping us plan to capture the best internal knowledge and skills from many different functions within the company (Marketing, Medical affairs, Regulatory, R&D, Sales) and to prepare the right strategic planning for NCEs and line extensions early in their development.

PHASE II International is ensuring we can get the right information, to the right stakeholders, at the right time and ultimately to get appropriate decisions about adopting our new product. This should in turn help ensure our market access communication is aligned to our marketing strategy for the brand.”

Frédéric Aziere
Strategic Area Therapeutic Manager
Galderma International